ByTrending Posts
Is Stanford’s MedAgentBench Setting the New Gold Standard…
Key Highlights AI benchmarking moves beyond knowledge tests: Unlike earlier evaluations that focused on exams like the USMLE,…
Will Apple’s FDA-Cleared Hypertension Detection Feature on the…
Key Highlights FDA Approval Unlocks a New Era in Preventive CareApple’s hypertension detection feature, cleared by the U.S.…
Is Novartis Deepening Its Bet on AI-Enabled Molecular…
Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has broadened its partnership…
Will Levita’s MARS Platform Redefine Solo Surgery with…
Key Highlights: Autonomous Camera Enables Solo Laparoscopic Surgery At Clínica Las Condes in Santiago, Chile, a gallbladder removal…
Will the FDA’s Panel Shape the Future of…
Key Highlights: Advisory Meeting to Tackle Generative AI in Mental Health The FDA has formally scheduled a meeting…
Will Tempus AI’s FDA Clearance Redefine the Future…
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Will GE HealthCare’s Acquisition of icometrix Redefine AI-Powered…
Chicago – GE HealthCare (Nasdaq: GEHC) announced it has entered into a definitive agreement to acquire icometrix, a…
Can BD’s Expanded Recall of Alaris™ Pump Infusion…
Key Insights BD’s updated recall follows internal testing that revealed infusion performance deviations, including flow rate accuracy issues,…
Can Johnson & Johnson’s Pact with Pacira BioSciences…
Key Insights Expanding Non-Surgical Pathways Through this agreement, Johnson & Johnson MedTech integrates ZILRETTA® into its Early Intervention…
Trending Posts
Latest Stories
Is China Outpacing the Global Biopharma Cycle? Innovation and Deal Momentum Accelerate
23 January 2026 Executive Summary China’s biopharma sector is continuing to advance at remarkable speed,…
Is China Becoming a Power Center for AI-Led Drug Discovery? Insilico Medicine Strikes $66 Million NLRP3 Licensing Deal
23 January 2026 Executive Summary Artificial-intelligence-driven drug developer Insilico Medicine has entered into a $66…
Is the U.S. Reopening the Door to Coverage Losses? ACA Subsidy Expiration Fuels Cost and Enrollment Uncertainty
23 January 2026 Executive Summary The expiration of enhanced Affordable Care Act (ACA) subsidies is…
Does the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal
23 January 2026 Executive Summary The United States has formally completed its withdrawal from the…
Gallery
